Back
Fulcrum Therapeutics Vs. Insmed Industry Stock Comparison
Sell
36
FULC
Fulcrum Therapeutics
Last Price:
3.27
Seasonality Move:
85.55%
Buy
55
INSM
Insmed
Last Price:
68.17
Seasonality Move:
7.96%
Sell
36
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.26. The Score for FULC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $68.15. The Score for INSM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight buying pressure.
INSM Stock Price Chart
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 36.2 | Sell |
| Chaikin Money Flow: | 30688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 3.64) | Sell |
| Bollinger Bands (100): | (3.96 - 8.8) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 38.39 | Sell |
| Chaikin Money Flow: | -24519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.77 - 74.15) | Sell |
| Bollinger Bands (100): | (68.63 - 76.17) | Sell |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.22 | Buy |
| 20-day SMA: | 3.38 | Sell |
| 50-day SMA: | 4.81 | Sell |
| 200-day SMA: | 7.45 | Sell |
| 8-day EMA: | 3.25 | Buy |
| 20-day EMA: | 3.48 | Sell |
| 50-day EMA: | 4.57 | Sell |
| 200-day EMA: | 6.38 | Sell |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.95 | Sell |
| 20-day SMA: | 71.83 | Sell |
| 50-day SMA: | 72.96 | Sell |
| 200-day SMA: | 51.26 | Buy |
| 8-day EMA: | 69.72 | Sell |
| 20-day EMA: | 71.24 | Sell |
| 50-day EMA: | 71.7 | Sell |
| 200-day EMA: | 56.51 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.78 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $1.30 per share.
Fulcrum Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||